United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2018_register
executive
2019-04-02
article
Prospective Grant of an Exclusive Patent License: Development and Commercialization of Cell Therapies for Cancer
Notices
D09002ee1bdb86821
D09002ee1bdb868a6
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
National Institutes of Health
originator
org
United States Government Agency or Subagency
The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the SUPPLEMENTARY INFORMATION section of this Notice to Tailored Therapeutics, LLC. (``Tailored''), located in Potomac, MD.
83 FR 49109
https://www.govinfo.gov/app/details/FR-2018-09-28/2018-21096
2018-21096
fr28se18-83
4140-01-P
https://www.govinfo.gov/app/details/FR-2018-09-28/2018-21096
https://www.govinfo.gov/content/pkg/FR-2018-09-28/html/2018-21096.htm
https://www.govinfo.gov/content/pkg/FR-2018-09-28/pdf/2018-21096.pdf
3 p.
49109
49111
83 FR 49109
Prospective Grant of an Exclusive Patent License: Development and Commercialization of Cell Therapies for Cancer; Federal Register Vol. 83, Issue
NOTICE
2018-21096
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
2018-10-15
4140-01-P
2018-21096
Notice.
The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the SUPPLEMENTARY INFORMATION section of this Notice to Tailored Therapeutics, LLC. (``Tailored''), located in Potomac, MD.
Only written comments and/or applications for a license which are received by the National Cancer Institute's Technology Transfer Center on or before October 15, 2018 will be considered.
Prospective Grant of an Exclusive Patent License:
Development and Commercialization of Cell Therapies for Cancer
,
andy.burke@nih.gov
Federal Register
Vol. 83, no. 189
Office of the Federal Register, National Archives and Records Administration
2018-09-28
continuing
daily
deposited
born digital
370 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2018-09-28
P0b002ee1a03a70f9
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr28se18
https://www.govinfo.gov/app/details/FR-2018-09-28
https://www.govinfo.gov/content/pkg/FR-2018-09-28/pdf/FR-2018-09-28.pdf
https://www.govinfo.gov/content/pkg/FR-2018-09-28/xml/FR-2018-09-28.xml
fdlp
48905
49263
DGPO
2019-04-02
2023-04-28
FR-2018-09-28
machine generated
eng
FR
FR-2018-09-28
83
189